Laura Francis
CIK 1218802 · Chief Executive Officer · last filed 2026-10-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SIBN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
471 EL CAMINO REAL, SUITE 101
SANTA CLARA, CA 95050
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SIBN | Chief Executive Officer | 747,385 | $21.31 | $15.93M | -$12.59M | 60 | 2026-10-14 |
| BRKRP | Director | 9,018 | $425.71 | $3.84M | $0 | 1 | 2026-02-18 |
| BRKR | Director | 4,498 | $58.23 | $261.9K | $0 | 1 | 2025-05-19 |
| Shockwave Medical, Inc. (SWAV) Delisted | Director | 0 | $334.75 | $0 | -$2.46M | 12 | 2024-05-31 |
Recent Filings · Page 3 of 9
86 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-19 | BRKR | Grant (A) | +4,498 | $0 | EDGAR |
| 2025-05-09 | SIBN | Sell (S) | −38,504 | -$661.4K | EDGAR |
| 2025-05-07 | SIBN | Notice (144) | −38,504 | -$633.4K | EDGAR |
| 2025-02-21 | SIBN | Sell (S) | −46,233 | -$795.9K | EDGAR |
| 2025-02-05 | SIBN | Grant (A) | +244,630 | $0 | EDGAR |
| 2024-11-20 | SIBN | Sell (S) | −10,048 | -$126.4K | EDGAR |
| 2024-08-20 | SIBN | Sell (S) | −9,967 | -$138.0K | EDGAR |
| 2024-06-17 | SIBN | Exer (M) | +68,669 | $300.7K | EDGAR |
| 2024-05-31 | Shockwave Medical, Inc. (SWAV) Delisted | Disp (D) | −4,784 | $0 | EDGAR |
| 2024-03-27 | Shockwave Medical, Inc. (SWAV) Delisted | Mixed | — | -$440.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.